Porton Pharma Solutions Ltd.

XSEC:300363 Stock Report

Market Cap: CN¥8.5b

Porton Pharma Solutions Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Nianfeng Ju

Chief executive officer

CN¥1.9m

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownership10.8%
Management average tenure2.8yrs
Board average tenure2.8yrs

Recent management updates

Recent updates

CEO

Nianfeng Ju (52 yo)

no data

Tenure

CN¥1,931,300

Compensation

Mr. Nianfeng Ju serves as General Manager of Porton Imp & Exp Ltd. Nianfeng Ju served as the General Manager of Porton Co., Ltd. He serves as a General Manager of Porton Pharma Solutions Ltd.Mr. Ju serves...

Leadership Team

NamePositionTenureCompensationOwnership
Nianfeng Ju
Chairman & GMno dataCN¥1.93m10.8%
CN¥ 918.1m
Hui Chen
Deputy GM & CFO2.8yrsCN¥1.59m0.0055%
CN¥ 467.7k
Yinchun Bai
Senior Deputy GM & COO2.8yrsCN¥1.65m0.029%
CN¥ 2.4m
Pi Wei
Deputy General Manager & Secretary2.8yrsCN¥714.90k0.016%
CN¥ 1.4m
Zhongneng Wang
Deputy General Manager2.8yrsCN¥1.39m0.026%
CN¥ 2.2m
Fengping Wang
Deputy General Manager2.8yrsCN¥2.09m0.020%
CN¥ 1.7m
Qi Chen
Deputy General Manager1.4yrsno datano data
Xiongbin Ma
Deputy General Manager1.4yrsno datano data
Yuanming Huang
Deputy General Manager1.4yrsno datano data

2.8yrs

Average Tenure

47yo

Average Age

Experienced Management: 300363's management team is considered experienced (2.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Nianfeng Ju
Chairman & GMno dataCN¥1.93m10.8%
CN¥ 918.1m
Weiqiang Yang
Non Independent Director3.4yrsCN¥180.00kno data
Guohua Cao
Independent Director4.3yrsCN¥180.00kno data
Hui Zeng
Employee Representative Supervisorno dataCN¥212.80kno data
Lin Yuan
Independent Director2.8yrsCN¥180.00kno data
Jinwei Pang
Independent Director2.8yrsCN¥180.00kno data
Yongqing Tan
Non-Employee Supervisory Board Chairmanno datano datano data
Ying Xue
Non-Independent Director4.3yrsCN¥180.00k0.0027%
CN¥ 228.8k
Jun Zhu
Director1.9yrsno datano data
Lina Hu
Non-Independent Director2.8yrsCN¥180.00kno data
Guojun Cao
Non-Independent Director2.8yrsCN¥180.00kno data
Yuchen Wu
Non-Employee Supervisor2.8yrsno datano data

2.8yrs

Average Tenure

56.5yo

Average Age

Experienced Board: 300363's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/19 13:26
End of Day Share Price 2025/01/17 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Porton Pharma Solutions Ltd. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jin ZhangChina International Capital Corporation Limited
Zhu ChenCitic Securities Co., Ltd.
Kai WangCitic Securities Co., Ltd.